190 related articles for article (PubMed ID: 3697988)
1. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.
Hollingsworth MA; Rebellato LM; Moore JW; Finn OJ; Metzgar RS
Cancer Res; 1986 May; 46(5):2482-7. PubMed ID: 3697988
[TBL] [Abstract][Full Text] [Related]
2. A novel ribonucleoprotein complex defined by monoclonal antibodies to NIH 3T3 cells transfected with human pancreatic adenocarcinoma DNA.
Hollingsworth MA; Borowitz MJ; Everett ML; Metzgar RS
Cancer Res; 1990 Sep; 50(18):6015-22. PubMed ID: 2393865
[TBL] [Abstract][Full Text] [Related]
3. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Roth JA; Scuderi P; Westin E; Gallo RC
Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
[TBL] [Abstract][Full Text] [Related]
5. [A study on reversion of the human activated c-Ha-ras-transformed cells].
Ogiso Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
[TBL] [Abstract][Full Text] [Related]
6. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
Su ZZ; Olsson CA; Zimmer SG; Fisher PB
Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547
[TBL] [Abstract][Full Text] [Related]
7. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
8. Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate.
FitzGerald TJ; Henault S; Sakakeeny M; Santucci MA; Pierce JH; Anklesaria P; Kase K; Das I; Greenberger JS
Radiat Res; 1990 Apr; 122(1):44-52. PubMed ID: 2320725
[TBL] [Abstract][Full Text] [Related]
9. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
Douvdevani A; Huleihel M; Segal S; Apte RN
Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
[TBL] [Abstract][Full Text] [Related]
10. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
11. A mutant cell line derived from NIH/3T3 cells: two oncogenes required for in vitro transformation.
Katz E; Carter BJ
J Natl Cancer Inst; 1986 Oct; 77(4):909-14. PubMed ID: 3463820
[TBL] [Abstract][Full Text] [Related]
12. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of c-onc genes in choriocarcinoma cells].
Fujino T
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):798-807. PubMed ID: 3692432
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
Blair DG; Cooper CS; Oskarsson MK; Eader LA; Vande Woude GF
Prog Clin Biol Res; 1983; 119():79-90. PubMed ID: 6346333
[TBL] [Abstract][Full Text] [Related]
15. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells.
Melchiori A; Carlone S; Allavena G; Aresu O; Parodi S; Aaronson SA; Albini A
Anticancer Res; 1990; 10(1):37-44. PubMed ID: 2334141
[TBL] [Abstract][Full Text] [Related]
16. Activation of c-Ki-ras gene in human pancreatic cancer.
Prassolov VS; Sakamoto H; Nishimura S; Terada M; Sugimura T
Jpn J Cancer Res; 1985 Sep; 76(9):792-5. PubMed ID: 3932275
[TBL] [Abstract][Full Text] [Related]
17. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
18. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
19. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
20. [Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].
Kniazev PG; Schäfer R; Kalinovskiĭ VP; Matveev BV; Mel'nikov RA
Mol Biol (Mosk); 1986; 20(6):1513-21. PubMed ID: 3027534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
